Videos / Updated indications for the recombinant, adjuvanted RSV vaccine
In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.
This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

Abnormal LFTs – Practical Cases Expert Q&A

MRAs for Heart Failure Update - New Developments

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

Practical Strategies to Increase Vaccination Rates This Flu Season

expert
Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital